Compare NMZ & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMZ | IRMD |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2014 |
| Metric | NMZ | IRMD |
|---|---|---|
| Price | $9.09 | $87.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $118.00 |
| AVG Volume (30 Days) | ★ 1.5M | 100.6K |
| Earning Date | 01-01-0001 | 11-02-2026 |
| Dividend Yield | ★ 5.08% | 0.93% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $9.85 |
| Revenue Next Year | N/A | $13.07 |
| P/E Ratio | ★ N/A | $99.86 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $8.69 | $71.34 |
| 52 Week High | $10.77 | $107.90 |
| Indicator | NMZ | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 56.39 |
| Support Level | $8.70 | $85.00 |
| Resistance Level | $10.52 | $88.59 |
| Average True Range (ATR) | 0.18 | 2.32 |
| MACD | 0.04 | 0.33 |
| Stochastic Oscillator | 51.66 | 87.09 |
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide high current income exempt from regular federal income tax. The Fund's secondary investment objective is to seek an attractive total return consistent with its primary objective.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.